azoxymethane has been researched along with glucagon-like peptide 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brubaker, PL; Iakoubov, R; Kim, YI; Lauffer, LM; Trivedi, S | 1 |
| Brubaker, PL; El-Zimaity, HM; Trivedi, S; Wiber, SC | 1 |
2 other study(ies) available for azoxymethane and glucagon-like peptide 2
| Article | Year |
|---|---|
Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice.
Topics: Animals; Azoxymethane; Cell Proliferation; Colonic Neoplasms; Glucagon-Like Peptide 2; Humans; Intestines; Mice; Mice, Inbred C57BL | 2009 |
Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer.
Topics: Animals; Azoxymethane; beta Catenin; Blotting, Western; Carcinogens; Colitis; Colonic Neoplasms; Dextran Sulfate; Diet, High-Fat; Doublecortin Protein; Glucagon-Like Peptide 2; Imidazoles; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2012 |